|
|
||||||||
MEMBRANE TRANSPORTERS, ION CHANNELS, AND PUMPS
1Laboratorio de Biofísica, Instituto de Investigaciones Médicas Mercedes y Martin Ferreira, Córdoba, Argentina; and 2Laboratorio de Permeabilidad Ionica, Instituto Venezolano de Investigaciones Científicas, Centro de Biofísica y Bioquímica, Caracas, Venezuela, and Marine Biological Laboratory, Woods Hole, Massachusetts
Submitted 12 October 2004 ; accepted in final form 13 January 2005
| ABSTRACT |
|---|
|
|
|---|
ionic-metabolic interactions
We recently proposed a comprehensive kinetic model for Na+/Ca2+ exchange regulation in squid axons that takes into consideration intracellular ionic interactions (Na+, Ca2+, and H+) and their connections with two metabolic routes: ATP and phosphoarginine (7). Basically, the model has the following features. First, binding of Ca2+ to the intracellular regulatory site is essential for Nai+ or Cai2+ binding to their transport sites. Second, Hi+, but not Nai+, competes with Cai2+ for the same form of the exchanger, resulting in competitive inhibition of Hi+ with Cai2+ at the regulatory Cai2+ site. Third, the binding of Nai+ to the protonized carrier allows the binding of a second proton, thus forming a dead end H2·E1·Na+-inhibitory complex. Fourth, MgATP, through a phosphorylation-requiring process, protects the exchanger by markedly decreasing its apparent affinity for Hi+ and Nai+ (6).
Recently, a new, potent, and selective inhibitor of the Na+/Ca2+ exchanger, SEA-0400 {SEA; 2-[4-[(2,5-difluorophenyl)methoxy]phenoxy]-5-ethoxyaniline}, has been synthesized (19, 25). This compound inhibits the NCX1 isoform with very high affinity (IC50 = 23 nM), seemingly by enhancing Nai+-dependent inactivation (I1 inactive state in Hilgemann et al.'s notation; see Ref.10) without affecting the Cai2+-antagonized I2 inactive state (3, 14, 17). Considering the kinetic model for the exchange regulation described above, it is important to investigate the effects of SEA in the squid nerve. Dialyzed squid giant axons allow accurate control of the intracellular H+ concentration ([H+]i), intracellular Na+ concentration ([Na+]i), intracellular Ca2+ concentration ([Ca2+]i), and intracellular ATP concentration ([ATP]i), thus making it an excellent preparation in which to explore the site (or sites) of action of SEA. Conversely, SEA can be used as a tool to examine the validity of our kinetic model of ionic and metabolic interactions with the exchanger and to clarify the reaction mechanism of this transporter. In the present article, we provide evidence that 1) SEA does act on the Nai+ inactivation process, but it also interacts with the H·E1 exchange conformation (6), and 2) the role of ATP protection against Hi+ + Nai+ synergic inhibition is supported by the marked reduction of SEA inhibition in the presence of the nucleotide, even at physiological [Na+]i.
| MATERIALS AND METHODS |
|---|
|
|
|---|
45 min with a standard medium containing 1 mM EGTA and free of Ca2+ and ATP. In all cases, each axon served as its own control because steady-state fluxes were measured before and after a given experimental condition. Reagents were obtained from Sigma Chemical (St. Louis, MO). Working temperature was between 17° and 18°C. SEA, provided by Taisho Pharmaceutical (Tokyo, Japan), was dissolved in dimethyl sulfoxide (DMSO) as a 10 mM stock solution and later diluted directly in the external or internal medium. The DMSO was always at or below 0.1%, a concentration without effect on the Na+/Ca2+ exchange fluxes. | RESULTS |
|---|
|
|
|---|
Km for the Cai2+ regulatory site at that [Na+]i in the absence of ATP (6).
In the axon shown in Fig. 1 and in the presence of full [Na+]o (440 mM) with no added Cao2+, the forward Nao+/Cai2+ exchange reaches a value of
240 fmol·cm2·s1. Replacement of Nao+ with Li+ in the presence of 3 mM Cao2+ induces a Ca2+/Cai2+ exchange of 125 fmol·cm2·s1. Upon addition of 3 µM external SEA, the Ca2+/Ca2+ exchange slowly drops by 50%. Upon returning to the initial conditions of 440 mM Nao+ and 0 Cao2+, the forward Na+/Ca2+ exchange reached only 170 fmol·cm2·s1, indicating a 37% inhibition by SEA on this exchange mode. Figure 2 displays a similar protocol used to explore the reverse mode of the exchanger (Cao2+-dependent 22Na efflux). In the presence of 440 mM Na+ and 0 Cao2+, the homologous Nao+/Nai+ exchange reached
12,000 fmol·cm2·s1; removal of Nao+ and addition of 3 mM Cao2+ (a saturating concentration in the presence of full Li+) produced a reverse exchange of
5,500 fmol·cm2·s1. In this case, 3 µM extracellular SEA reduced the reverse exchange to
3,200 fmol·cm2·s1, corresponding to a 42% inhibition. In contrast, under conditions otherwise similar to those used before {40 mM [Na+]i, 5 µM [Ca2+]i, no ATP and intracellular pH (pHi) 7.3}, Fig. 3 shows that 3 µM intracellular SEA reduced Nao+-dependent 45Ca2+ efflux (forward) from 230 to 50 fmol·cm2·s1, which amounts to
80% inhibition. This value is significantly higher than that observed when SEA was applied externally. A dose-response curve for cytosolic SEA inhibition of the forward Na+/Ca2+ exchange is shown in Fig. 4. The experimental points were fitted to a Michaelis-Menten equation, resulting in Ki of 1 ± 0.15 µM (n = 14). At the high ionic strength used in our dialysis solutions, this value is >50 times higher than that reported for mammalian tissues (17, 19, 25) (see DISCUSSION).
|
|
|
|
|
|
200 fmol·cm2·s1 at pHi 7.3 increased to
736 fmol·cm2·s1 when the cytosol was alkalinized to pH 8.5. Subsequent addition of 3 µM SEA to the dialysis medium produced only a minor reduction in Ca2+ efflux to 689 fmol·cm2·s1, i.e., a 7% inhibition. Thus, still in the presence of 40 mM Nai+, alkalinization strongly antagonizes SEA inhibition. We already know that in squid axons in which the Nai+ has been removed completely, intracellular acidification inhibits the exchanger (see Fig. 10 and Ref.6); in our model, this is due to the binding of the first proton to the Na+-free carrier. Figure 8 shows an experiment designed to explore the pHi dependence of SEA inhibition in the complete absence of Nai+. Note that without Nai+ and at pH 7.3, the Nao+-dependent Ca2+ efflux (forward exchange) was markedly stimulated, reaching a steady-state level of 1,100 fmol·cm2·s1. A subsequent reduction of pHi to 6.7 induced a substantial inhibition of the exchange activity to 427 fmol·cm2·s1. Under this acidic condition and in the absence of Nai+ and ATP, 3 µM internal SEA caused a 44% inhibition of the Na+/Ca2+ exchange flux. Interestingly, in the continuous presence of SEA, returning the pHi from 6.7 to 7.3 in the absence of Nai+ returned the Nao+-dependent Ca2+ efflux to its initial values. In contrast to the reversibility of Hi+ inhibition in the presence of SEA, Fig. 9 shows that removal of SEA while the pH remained acidic did not result in any recovery of the exchange fluxes. Figure 10 summarizes the results of 14 different experiments of the type shown in Figs. 7 and 8, in which the pHi dependence of 3 µM internal SEA inhibition was measured in axons dialyzed in the presence and absence of Nai+ and containing 5 µM Cai2+ and 0 ATP. It is clear that both Nai+ and Hi+ synergistically promote SEA inhibition or, in other words, that SEA promotes the synergic Hi+ + Nai+ inhibition of the exchanger.
|
|
|
|
|
| DISCUSSION |
|---|
|
|
|---|
-2 repeat region of the exchanger plays a critical role in the inhibition process (13). On the other hand, SEA inhibits cardiac and neuronal Na+/Ca2+ exchange with an affinity and specificity higher than that of any presently known inhibitor (2, 17, 25). Measurements of Nai+-dependent Ca2+ uptake and whole cell Na+/Ca2+ exchange currents in NCX1-transfected fibroblast and exchange currents in giant excised membrane patches from oocytes also transfected with NCX1.1 (3, 17) indicate that SEA stabilizes the transition of NCX1 into a Nai+-dependent inactive state (I1). In addition, exchangers with the inhibitor peptide region mutated or mutants with suppressed I1 inactivation (
229232, K229Q, and Y224W/Y226W/Y228W/Y231W) have shown markedly reduced sensitivity to SEA (3, 14).
In the present work, we have studied the effects of extra- and intracellular SEA on steady-state outward (forward exchange), inward (reverse exchange), and Ca2+/Ca2+ modes of the Na+/Ca2+ exchanger. Although previous studies with SEA revealed mostly changes in the peak outward Na+/Ca2+ exchange currents, the data also show that SEA inhibits steady-state currents (3). In our experiments, the enhancement by SEA of Nai+ inhibition of the Na+/Ca2+ exchanger almost certainly reflects Nai+ interaction at the Na+ inactivation site, because 1) Nai+ inactivation is strongly increased by protons, 2) ATP and intracellular alkalinization relieve inhibition, 3) Nai+ and Hi+ synergically promote SEA effects, and 4) internal acidification favors SEA inhibition even in the absence of Nai+. In other words, the relationships between SEA inhibition and ligands interacting with the intracellular loop can be fully accounted for by the model recently proposed for regulation of the squid Na+/Ca2+ exchanger (6). The normal ATP concentration in a squid axon is
34 mM. Therefore, the inhibitory potency of SEA is expected to be largely diminished under physiological conditions. Actually, this hypothesis is in line with a recent work, published while this article was in preparation, in which inhibition by SN-6, a new benzyloxyphenyl derivative, in NCX1-transfected cells occurred in the inhibitory peptide region (related to Nai+ inhibition) and was enhanced by intracellular ATP depletion (15). These results strongly support our proposed model in which the site of SEA inhibition is intracellular and acts through Nai+-Hi+ synergy, which in turn is modulated by ATP level (Fig. 11),
Another interesting feature of our present results is that some characteristics of SEA inhibition described for NCX1 are not reproduced in squid axons. The inhibition does not occur mainly in the reverse exchange mode, but the three investigated modes (forward, reverse, and Ca2+/Ca2+ exchange) are affected. Also, we found no evidence that inhibition takes place preferentially from outside the membrane. To the contrary, the forward exchange is inhibited >80% from inside the axon, compared with only 4050% from the external surface. As pointed out above, the data support the notion that SEA acts at or very near the intracellular loop of the exchanger (see Ref.3). The fact that the observed onset times of SEA inhibition of the forward Na+/Ca2+ exchange are not very different from those observed outside (Fig. 1) or inside the axon (Fig. 3) does not mean that the actual rates are the same. Figures 2 and 3 show that the washout of Na+ from the extracellular side takes place in <6 min. On the other hand, in the intracellular phase (see Fig. 5), that washout takes >20 min. These differences are due to geometry that makes the accessibility to extracellular Na+ sites easier than that associated with sites located inside the membrane. This point is also illustrated in Fig. 5, in which full stimulation of the exchanger by 3 mM ATP (>10 times the Km) occurs after
30 min of its inclusion in the dialysis solution. Therefore, one should expect much faster inhibition of the exchanger by external application of SEA if the inhibitor is acting on an extracellular site. Nevertheless, we cannot rule out completely an additional external site involved in SEA inhibition. It could be argued that changes in pHi may affect SEA inhibition through changes in its state of protonation. SEA is a 2,5-dimethoxyaniline. In general, the acidic dissociation constant (pKa) of anilines is
4.0; actually, a compound with a closely related structure, the 3,5-dimethoxy aniline, has a pKa of 3.82 (16). Consequently, at pH
6.7, practically all SEA are in a nonprotonated state. This makes it unlikely that a variation in pHi explored in the present study, particularly alkalinization from pH 7.3 to 8.5 that prevents inhibition, will significantly modify the amount of unprotonated SEA molecules.
Under favorable conditions (with 40 mM Nai+, pH 7.3, and no ATP or with pHi 6.7, no ATP, and even without Nai+), inhibition by SEA cannot be reversed for at least
1 h after its removal from the dialysis solution (see Fig. 9). One explanation for the irreversibility of SEA inhibition may be an actually very slow off rate constant for binding to the exchanger. Another alternative is that because of its known high hydrophobicity, it is very difficult to remove it from the lipid environment of the membrane; this requires a hydrophobic region around its actual binding site in the exchanger molecule. In addition, a nonspecific accumulation of SEA in glass pipettes and infusion tubes cannot be ruled out. On the other hand, removal of the cointeracting agent of inhibition, Nai+ (Fig. 5) or Hi+ (alkalinization; see Fig. 8), even in the continuous presence of SEA, leads to a clear release of inhibition. The fact that the Ki for SEA at a high ionic strength of squid axons is 1 µM (>50 times higher than in mammalian NCX) makes it difficult to conclude that the absence of reversibility is due to the presence of an SEA concentration of
3 µM in the SEA-free solutions. The almost inescapable conclusion is that SEA binds quite tightly to the exchanger, and as a consequence of that binding, it facilitates the reversible attachment of the natural Hi+ + Nai+ synergic inhibitors.
In summary, our data provide a new, extended explanation for the mechanisms underlying SEA inhibition of the Na+/Ca2+ exchanger. This compound not only enhances Nai+-dependent inactivation but also stabilizes the conformation of the exchanger bound to the first proton. Further experiments are required to explore whether the ligand interactions regulated by phosphoarginine, too, are a target for SEA inhibition. We think that further investigations into the mechanism by which this novel inhibitor acts could produce beneficial pharmacological information and contribute to the understanding of the molecular basis for the regulation of the Na+/Ca2+ exchanger.
| GRANTS |
|---|
|
|
|---|
| FOOTNOTES |
|---|
The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
| REFERENCES |
|---|
|
|
|---|
2. Blaustein MP and Lederer WJ. Sodium/calcium exchange: its physiological implications. Physiol Rev 79: 763854, 1999.
3. Bouchard R, Omelchenko A, Le HD, Choptiany P, Matsuda T, Baba A, Takahashi K, Nicoll DA, Philipson KD, Hnatowich M, and Hryshko LV. Effects of SEA0400 on mutant NCX1.1 Na+-Ca2+ exchangers with altered ionic regulation. Mol Pharmacol 65: 802810, 2004.
4. DiPolo R, Berberián G, Delgado D, Rojas H, and Beaugé L. A novel 13 kDa cytoplasmic soluble protein is required for the nucleotide (MgATP) modulation of the Na/Ca exchange in squid nerve fibers. FEBS Lett 401: 610, 1997.[CrossRef][ISI][Medline]
5. DiPolo R and Beaugé L. Metabolic regulation of the Na/Ca exchange, the role of phosphorylation and dephosphorylation. Biochim Biophys Acta 1422: 5771, 1999.[Medline]
6. DiPolo R and Beaugé L. MgATP counteracts intracellular proton inhibition of the sodium-calcium exchanger in dialysed squid axons. J Physiol 539: 791803, 2002.
7. DiPolo R, Berberián G, and Beaugé L. Phosphoarginine regulation of the squid nerve Na+/Ca2+ exchanger: metabolic pathway and exchanger-ligand interactions different from those seen with ATP. J Physiol 554: 387401, 2003.[Medline]
8. Doering AE and Lederer WJ. The action of Na+ as a cofactor in the inhibition by cytoplasmic protons of the cardiac Na+-Ca2+ exchanger in the guinea-pig. J Physiol 480: 920, 1994.
9. Hilgemann DW, Collins A, and Matsuoka S. Steady-state and dynamic properties of cardiac sodium-calcium exchange: secondary modulation by cytoplasmic calcium and ATP. J Gen Physiol 100: 933961, 1992.
10. Hilgemann DW, Matsuoka S, Nagel GA, and Collins A. Steady-state and dynamic properties of cardiac sodium-calcium exchange: sodium-dependent inactivation. J Gen Physiol 100: 905932, 1992.
11. Hilgemann DW. Cytoplasmic ATP-dependent regulation of ion transporters and channels: mechanisms and messengers. Annu Rev Physiol 59: 193220, 1997.[CrossRef][ISI][Medline]
12. Iwamoto T, Watano T, and Shigekawa M. A novel isothiourea derivative selectively inhibits the reverse mode of Na+/Ca2+ exchange in cells expressing NCX1. J Biol Chem 271: 2239122397, 1996.
13. Iwamoto T, Kita S, Uchara A, Inoue Y, Taniguchi Y, Imanaga I, and Shigekawa M. Structural domains influencing sensitivity to isothiourea derivative inhibitor KB-R7943 in cardiac Na+/Ca2+ exchanger. Mol Pharmacol 59: 524531, 2001.
14. Iwamoto T, Kita S, Uehara A, Imanaga I, Matsuda T, Baba A, and Katsuragi T. Molecular determinants of Na+/Ca2+ exchange (NCX1) inhibition by SEA0400. J Biol Chem 279: 75447553, 2004.
15. Iwamoto T, Inoue Y, Ito K, Sakaue T, Kita S, and Katsuragi T. The exchanger inhibitory peptide region-dependent inhibition of Na+/Ca2+ exchange by SN-6 [2-[4-(4-nitrobenzyloxy)benzyl]thiazolidine-4-carboxylic acid ethyl ester], a novel benzyloxyphenyl derivative. Mol Pharmacol 66: 4555, 2004.
16. Jencks WP and Regenstein T. Ionization constants of acids and bases. In: CRC Handbook of Biochemistry and Molecular Biology (3rd ed.), edited by Fasman GD. Boca Raton, FL: CRC, 1977, vol. 1, p. 327328.
17. Lee C, Visen NS, Dhalla NS, Le HD, Isaac M, Choptiany P, Gross G, Omelchenko A, Matsuda T, Baba A, Takahashi K, Hnatowich M, and Hryshko LV. Inhibitory profile of SEA0400 [2-[4-[(2,5-difluorophenyl)methoxy]phenoxy]-5-ethoxyaniline] assessed on the cardiac Na+-Ca2+ exchanger, NCX1.1. J Pharmacol Exp Ther 311: 748757, 2004.
18. Magee WP, Deshmukh G, Deninno MP, Sutt JC, Chapman JG, and Tracey WR. Differing cardioprotective efficacy of the Na+/Ca2+ exchanger inhibitors SEA0400 and KB-R7943. Am J Physiol Heart Circ Physiol 284: H903H910, 2003.
19. Matsuda T, Arakawa N, Takuma K, Kishida Y, Kawasaki Y, Sakaue M, Takahashi K, Takahashi T, Suzuki T, Ota T, Hamano-Takahashi A, Onishi M, Tanaka Y, Kameo K, and Baba A. SEA0400, a novel and selective inhibitor of the Na+-Ca2+ exchanger, attenuates reperfusion injury in the in vitro and in vivo cerebral ischemic models. J Pharmacol Exp Ther 298: 249256, 2001.
20. Ogata M, Iwamoto T, Tazawa N, Nishikawa M, Yamashita J, Takaoka M, and Matsumura Y. A novel and selective Na+/Ca2+ exchange inhibitor, SEA0400, improves ischemia/reperfusion-induced renal injury. Eur J Pharmacol 478: 187198, 2003.[CrossRef][ISI][Medline]
21. Requena J. Calcium efflux from squid axons under constant sodium electrochemical gradient. J Gen Physiol 72: 443470, 1978.
22. Reuter H, Henderson SA, Han T, Matsuda T, Baba A, Ross RS, Goldhaber JI, and Philipson KD. Knockout mice for pharmacological screening: testing the specificity of Na+-Ca2+ exchange inhibitors. Circ Res 91: 9092, 2002.
23. Shigekawa M and Iwamoto T. Cardiac Na+-Ca2+ exchange: molecular and pharmacological aspects. Circ Res 88: 864876, 2001.
24. Takahashi K, Takahashi T, Suzuki T, Onishi M, Tanaka Y, Hamano-Takahashi A, Ota T, Kameo K, Matsuda T, and Baba A. Protective effects of SEA0400, a novel and selective inhibitor of the Na+/Ca2+ exchanger, on myocardial ischemia-reperfusion injuries. Eur J Pharmacol 458: 155162, 2003.[CrossRef][ISI][Medline]
25. Tanaka H, Nishimaru K, Aikawa T, Hirayama W, Tanaka Y, and Shigenobu K. Effect of SEA0400, a novel inhibitor of sodium-calcium exchanger, on myocardial ionic currents. Br J Pharmacol 135: 10961100, 2002.[CrossRef][ISI][Medline]
26. Watano T, Kimura J, Morita T, and Nakanishi H. A novel antagonist, no. 7943, of the Na+/Ca2+ exchange current in guinea-pig cardiac ventricular cells. Br J Pharmacol 119: 555563, 1996.[ISI][Medline]
This article has been cited by other articles:
![]() |
R. Dipolo and L. Beauge Sodium/Calcium Exchanger: Influence of Metabolic Regulation on Ion Carrier Interactions Physiol Rev, January 1, 2006; 86(1): 155 - 203. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |